Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
1,078,658
-
Share change
-
-1,346,813
-
Total reported value
-
$1,327,000
-
Price per share
-
$1.24
-
Number of holders
-
6
-
Value change
-
-$1,369,552
-
Number of buys
-
1
-
Number of sells
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q2 2017
As of 30 Jun 2017,
Aptose Biosciences Inc. - Common Shares was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,078,658 shares.
The largest 7 holders included
Cormorant Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, and Parallax Volatility Advisers, L.P..
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.